Commonwealth Bank of Australia’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Commonwealth Bank of Australia’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-19,810	Closed	-$396K	–	1256
2014 Q1	$396K	Buy	19,810 +600	+3%	+$11.6K	﹤0.01%	1095
2013 Q4	$322K	Sell	19,210 -13,690	-42%	-$189K	﹤0.01%	1120
2013 Q3	$349K	Buy	32,900 +800	+2%	+$7K	﹤0.01%	1059
2013 Q2	$179K	Buy	+32,100	New	+$194K	﹤0.01%	1113

Other funds holding ANAC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Commonwealth Bank of Australia's ANAC Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2014, closing a stake of 19,810 shares — an estimated $396K sold.

Commonwealth Bank of Australia first reported a position in ANAC in Q2 2013 and held it in 4 quarters. The position peaked at $396K in Q1 2014. 107 funds tracked by Wall St. Rank hold ANAC as of Q2 2014.

Commonwealth Bank of Australia reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 19,810 ANACOR PHARMACEUTICALS INC COM shares in Q2 2014, an estimated $396K.
Commonwealth Bank of Australia first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's ANACOR PHARMACEUTICALS INC COM position peaked at $396K in Q1 2014.
107 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.